Publications by authors named "Ana Szarfman"

Claim this Profile
S
Signaling COVID-19 Vaccine Adverse Events.
Rave Harpaz, William DuMouchel, Robbert Van Manen, Alexander Nip, Steve Bright, Ana Szarfman

Drug Saf· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for achieving interoperable and shareable medical data in the USA.
Ana Szarfman, Jonathan G Levine, Joseph M Tonning, Frank Weichold, John C Bloom

Commun Med (Lond)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Concept Value Sets and Interoperability in Health Data Analytics.
Sigfried Gold, Andrea Batch, Robert McClure, Guoqian Jiang, Hadi Kharrazi, Ana Szarfman

AMIA Annu Symp Proc· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory Forum Review*: Utility of in Vitro Secondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory Considerations.
Thomas Papoian, Gowraganahalli Jagadeesh, Muriel Saulnier, Natalie Simpson, Arippa Ravindran, Ana Szarfman

Toxicol Pathol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of data mining at the Food and Drug Administration.
Hesha J Duggirala, Joseph M Tonning, Ella Smith, Roselie A Bright, John D Baker, Ana Szarfman

J Am Med Inform Assoc· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.
Rainer Winnenburg, Alfred Sorbello, Anna Ripple, Rave Harpaz, Joseph Tonning, Ana Szarfman

J Biomed Inform· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A time-indexed reference standard of adverse drug reactions.
Rave Harpaz, David Odgers, Greg Gaskin, William DuMouchel, Rainer Winnenburg, Ana Szarfman

Sci Data· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children.
Scott A Rivkees, Ana Szarfman

J Clin Endocrinol Metab· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An evaluation of a data mining signal for amyotrophic lateral sclerosis and statins detected in FDA's spontaneous adverse event reporting system.
Eric Colman, Ana Szarfman, Jo Wyeth, Andrew Mosholder, Devanand Jillapalli

Pharmacoepidemiol Drug Saf· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
Ana Szarfman, Joseph M Tonning, Jonathan G Levine, P Murali Doraiswamy

Pharmacotherapy· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between pathologic gambling and parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database.
Ana Szarfman, P Murali Doraiswamy, Joseph M Tonning, Jonathan G Levine

Arch Neurol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on the use of data mining in pharmaco-vigilance.
June Almenoff, Joseph M Tonning, A Lawrence Gould, Ana Szarfman, Manfred Hauben

Drug Saf· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: The evaluation of data mining methods for the simultaneous and systematic detection of safety signals in large databases: lessons to be learned.
Jonathan G Levine, Joseph M Tonning, Ana Szarfman

Br J Clin Pharmacol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacovigilance in the 21st century: new systematic tools for an old problem.
Ana Szarfman, Joseph M Tonning, P Murali Doraiswamy

Pharmacotherapy· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of long-term toxicities of HIV treatments: an international perspective.
Greg Bisson, Robert Gross, Veronica Miller, Ian Weller, Alexander Walker, Ana Szarfman

AIDS· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.
Ana Szarfman, Stella G Machado, Robert T O'Neill

Drug Saf· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis